WO2012173809A3 - Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders - Google Patents
Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders Download PDFInfo
- Publication number
- WO2012173809A3 WO2012173809A3 PCT/US2012/040795 US2012040795W WO2012173809A3 WO 2012173809 A3 WO2012173809 A3 WO 2012173809A3 US 2012040795 W US2012040795 W US 2012040795W WO 2012173809 A3 WO2012173809 A3 WO 2012173809A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- identifying
- cnv
- disorders
- copy number
- number variants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
The present disclosure relates to methods of identifying copy number variation (CNV) events and sizes that are associated with attention problems (AP) and identifying one or more CNVs which correlate with such disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161492783P | 2011-06-02 | 2011-06-02 | |
US61/492,783 | 2011-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012173809A2 WO2012173809A2 (en) | 2012-12-20 |
WO2012173809A3 true WO2012173809A3 (en) | 2013-04-04 |
Family
ID=47357667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/040795 WO2012173809A2 (en) | 2011-06-02 | 2012-06-04 | Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012173809A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106701900B (en) * | 2015-11-16 | 2020-03-20 | 上海市东方医院 | Long-chain non-coding RNA HERC2P3 gene and application thereof in gastric cancer |
CN107423534B (en) * | 2016-05-24 | 2021-08-06 | 郝柯 | Method and system for detecting genome copy number variation |
CN111028890B (en) * | 2019-12-31 | 2020-09-11 | 东莞博奥木华基因科技有限公司 | CNV detection method based on correction between run |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009105718A1 (en) * | 2008-02-20 | 2009-08-27 | The Children's Hospital Of Philadelphia | Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatmemt of autism |
US20090307180A1 (en) * | 2008-03-19 | 2009-12-10 | Brandon Colby | Genetic analysis |
US20100143921A1 (en) * | 2007-04-30 | 2010-06-10 | The Ohio State University Research Foundation | Polymorphisms in Genes Affecting Dopamine Transporter Disorders and Uses Thereof |
US20100248235A1 (en) * | 2007-10-04 | 2010-09-30 | Scherer Stephen W | Biomarkers for autism spectrum disorders |
US20110111419A1 (en) * | 2008-07-04 | 2011-05-12 | deCODE Geneties ehf. | Copy Number Variations Predictive of Risk of Schizophrenia |
-
2012
- 2012-06-04 WO PCT/US2012/040795 patent/WO2012173809A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100143921A1 (en) * | 2007-04-30 | 2010-06-10 | The Ohio State University Research Foundation | Polymorphisms in Genes Affecting Dopamine Transporter Disorders and Uses Thereof |
US20100248235A1 (en) * | 2007-10-04 | 2010-09-30 | Scherer Stephen W | Biomarkers for autism spectrum disorders |
WO2009105718A1 (en) * | 2008-02-20 | 2009-08-27 | The Children's Hospital Of Philadelphia | Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatmemt of autism |
US20090307180A1 (en) * | 2008-03-19 | 2009-12-10 | Brandon Colby | Genetic analysis |
US20110111419A1 (en) * | 2008-07-04 | 2011-05-12 | deCODE Geneties ehf. | Copy Number Variations Predictive of Risk of Schizophrenia |
Non-Patent Citations (1)
Title |
---|
ERIK A. EHLI ET AL.: "De novo and inherited CNVs in MZ twin pairs selected for discordance and concordance on Attention Problems", EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 20, no. 10, 11 April 2012 (2012-04-11), pages 1037 - 1043 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012173809A2 (en) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2857401B8 (en) | NOVEL ß-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME | |
GB2493999B (en) | Microorganism having enhanced l-valine productivity and method for producing l-valine using the same | |
EP2797380A4 (en) | Method, entity and system for realizing cluster service | |
WO2013022744A3 (en) | Optical element for correcting color blindness | |
WO2012149472A9 (en) | Methods, compositions, and kits for treating and preventing neurological conditions | |
MX2013001045A (en) | Liver organoid, uses thereof and culture method for obtaining them. | |
WO2013026740A3 (en) | Methods and means to modify a plant genome | |
WO2012058494A3 (en) | Isoprene synthase variants for improved production of isoprene | |
EP2682366A4 (en) | Method for producing graphene, graphene produced on substrate, and graphene on substrate | |
PT2593556T (en) | Enzymatic method for (r)-selective amination | |
EP2691994A4 (en) | Photovoltaic cell tab and method and system for forming photovoltaic cell tabs | |
EP2675622A4 (en) | Apparatus and methods for impinging fluids on substrates | |
EP2405005A4 (en) | Microorganism which produces l-amino acid and method for producing l-amino acid using the same | |
BR112017001177A2 (en) | process for purifying poliovirus from cell cultures | |
EP3164495A4 (en) | Microorganisms for producing 4c-5c compounds with unsaturation and methods related thereto | |
IL232741A0 (en) | Methods for the preparation of hydrogels using lipase enzymes | |
EP3868863A4 (en) | Cell culture substrate, method for producing cell culture substrate, and method for producing spheroids | |
WO2012166454A3 (en) | Shape-based advertising for electronic visual media | |
EP2405006A4 (en) | Microorganism which produces l-amino acid and method for producing l-amino acid using the same | |
EP2674490A4 (en) | Phenylpyruvate reductase and method for manufacturing optically-active phenyllactic acid and 4-hydroxyl-phenyllactic acid using same enzyme | |
WO2011119986A3 (en) | Methods for culturing and analyzing cells | |
WO2012173809A3 (en) | Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders | |
WO2012148604A3 (en) | Method for aligned transfer of thin membranes to substrates | |
EP2709441A4 (en) | Plants having one or more enhanced yield- related traits and method for making the same | |
WO2012154271A3 (en) | Method and cells for identifying rig-i pathway regulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12799799 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12799799 Country of ref document: EP Kind code of ref document: A2 |